…
3i Group plc is a private equity firm specializing in mature companies, growth capital, middle markets, infrastructure, and management leveraged buyouts and buy-ins. The firm also provides infrastructure financing and debt management. For debt management, it invests in senior and mezzanine corporate debt in typically large and private companies in United Kingdom, Europe, Asia, and North America. It makes private equity investments in business and technology services, financial services, consumer and private label, software and service, healthcare, consumption and distribution, media and telecom, renewable energy, wind, and industrial technology sector. Within business and technology services, the firm seeks to invest in sub sectors such as testing, inspection and certification; intelligent outsourcing, BPO and consultancy; human capital including staffing, governance, risk and compliance, services to pharmaceutical companies, vertical application software, education and training businesses; facilities management; support services to industrial sectors such as oil and gas and utilities; human resources outsourcing and advising; recruitment; logistics and infrastructure support services including distribution, waste, and rental. In the consumer sector, it focuses on, multi-unit roll out, omni-channel propositions, niche branded consumer goods, polarization, health and wellness, ageing population, millennials, consumer goods; e-commerce; retail; food and drinks; private label CMO and leisure. In the healthcare sector, the firm focuses on outsourced medical device manufacturing & services, outsourced pharmaceutical manufacturing & services, bioprocessing supply chain, life science tools and diagnostics, wellness & consumer health products, personalized medicine, pharmaceuticals and biotechnology including specialty pharma, generics or OTC, drug delivery, and animal health; healthcare services including activities such as elderly and specialty care, including caring for people in their own homes, in hospital and in co
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Income before tax | 5039.00M | 3838.00M | 4575.00M | 4018.00M | 1855.00M |
| Net income | 5038.00M | 3836.00M | 4573.00M | 4013.00M | 1855.00M |
| Selling general administrative | 32.00M | 34.00M | 137.00M | 127.00M | 111.00M |
| Selling and marketing expenses | - | 110.00M | - | - | - |
| Gross profit | 5189.00M | 3977.00M | 4712.00M | 4145.00M | 1966.00M |
| Reconciled depreciation | 12.00M | 8.00M | 6.00M | 7.00M | 7.00M |
| Ebit | 5039.00M | 3816.00M | 4661.00M | 4117.00M | 1855.00M |
| Ebitda | 5051.00M | 3824.00M | 4667.00M | 4124.00M | 1862.00M |
| Depreciation and amortization | 12.00M | 8.00M | 6.00M | 7.00M | 7.00M |
| Operating income | 5039.00M | 3824.00M | 4661.00M | 4117.00M | 1855.00M |
| Other operating expenses | 229.00M | 153.00M | 137.00M | 125.00M | 111.00M |
| Interest expense | 79.00M | 112.00M | 92.00M | 99.00M | 54.00M |
| Tax provision | 1.00M | 2.00M | 2.00M | 5.00M | 0.00M |
| Interest income | 73.00M | 100.00M | 74.00M | 83.00M | 27.00M |
| Net interest income | -6.00M | -12.00M | -18.00M | -16.00M | -27.00M |
| Income tax expense | 1.00M | 2.00M | 2.00M | 5.00M | 54.00M |
| Total revenue | 5268.00M | 3977.00M | 4712.00M | 4145.00M | 1966.00M |
| Total operating expenses | 150.00M | 153.00M | 137.00M | 127.00M | 111.00M |
| Cost of revenue | 79.00M | 3465.00M | - | - | - |
| Total other income expense net | - | 14.00M | -86.00M | -99.00M | -54.00M |
| Net income from continuing ops | 5038.00M | 3836.00M | 4573.00M | 4013.00M | 1855.00M |
| Net income applicable to common shares | - | - | - | 4012.00M | 1855.00M |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Total assets | 26056.00M | 21641.00M | 17819.00M | 14842.00M | 10334.00M |
| Intangible assets | 2.00M | 4.00M | - | - | 8.00M |
| Other current assets | - | 130.00M | - | 210.00M | 112.00M |
| Total liab | 1445.00M | 1471.00M | 975.00M | 2088.00M | 1170.00M |
| Total stockholder equity | 24611.00M | 20170.00M | 16844.00M | 12754.00M | 9164.00M |
| Other current liab | -1.00M | 66.00M | -110.00M | -129.00M | -79.00M |
| Common stock | 719.00M | 719.00M | 719.00M | 719.00M | 719.00M |
| Capital stock | 719.00M | 719.00M | 719.00M | 719.00M | 719.00M |
| Retained earnings | - | 1519.00M | - | 1125.00M | 916.00M |
| Other liab | - | - | - | 966.00M | 98.00M |
| Other assets | - | -190.00M | 114.00M | 210.00M | 131.00M |
| Cash | 412.00M | 358.00M | 162.00M | 229.00M | 216.00M |
| Total current liabilities | 145.00M | 165.00M | 110.00M | 129.00M | 79.00M |
| Current deferred revenue | - | -4.00M | - | - | - |
| Net debt | 827.00M | 893.00M | 623.00M | 760.00M | 776.00M |
| Short term debt | - | 4.00M | - | - | - |
| Short long term debt total | 1239.00M | 1251.00M | 785.00M | 989.00M | 992.00M |
| Other stockholder equity | 23892.00M | 699.00M | 16125.00M | 12035.00M | 8445.00M |
| Property plant equipment | - | - | - | 16.00M | 21.00M |
| Total current assets | 445.00M | 537.00M | 205.00M | 288.00M | 233.00M |
| Long term investments | 25409.00M | 21041.00M | 17483.00M | 14322.00M | 9941.00M |
| Net tangible assets | - | - | - | 12748.00M | 9156.00M |
| Short term investments | - | 186.00M | - | - | - |
| Net receivables | 33.00M | 49.00M | 43.00M | 59.00M | 17.00M |
| Long term debt | - | - | - | - | 975.00M |
| Accounts payable | 145.00M | 96.00M | 110.00M | 129.00M | 79.00M |
| Accumulated other comprehensive income | - | 17233.00M | - | - | - |
| Common stock total equity | - | - | - | - | 719.00M |
| Non currrent assets other | 18497.00M | 196.00M | -17500.00M | -14344.00M | -9970.00M |
| Non current assets total | 25611.00M | 21294.00M | 17500.00M | 14344.00M | 9970.00M |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Investments | -16.00M | -3.00M | -1.00M | 0.00M | -1.00M |
| Change to liabilities | - | - | - | 0.00M | 0.00M |
| Total cashflows from investing activities | -16.00M | -3.00M | - | - | -1.00M |
| Net borrowings | -6.00M | 416.00M | - | -4.00M | 390.00M |
| Total cash from financing activities | -690.00M | -164.00M | -773.00M | -498.00M | 7.00M |
| Net income | 5038.00M | 3836.00M | 4573.00M | 4013.00M | 1855.00M |
| Change in cash | 54.00M | 196.00M | 183.00M | 4.00M | -555.00M |
| Begin period cash flow | 358.00M | 162.00M | 229.00M | 225.00M | 771.00M |
| End period cash flow | 412.00M | 358.00M | 412.00M | 229.00M | 216.00M |
| Total cash from operating activities | 763.00M | 366.00M | 4573.00M | 4020.00M | -559.00M |
| Issuance of capital stock | 1.00M | 1.00M | 1.00M | 1.00M | 1.00M |
| Depreciation | - | 8.00M | - | 7.00M | 7.00M |
| Dividends paid | 625.00M | 541.00M | 485.00M | 389.00M | 338.00M |
| Sale purchase of stock | - | 0.00M | -30.00M | -54.00M | 1.00M |
| Other cashflows from financing activities | -60.00M | -40.00M | -54.00M | -52.00M | 349.00M |
| Change to netincome | - | - | - | -3512.00M | -2421.00M |
| Capital expenditures | 16.00M | 3.00M | 1.00M | 0.00M | 1.00M |
| Change in working capital | - | - | - | - | 39.00M |
| Stock based compensation | - | 39.00M | - | - | - |
| Other non cash items | 763.00M | -3478.00M | -4573.00M | -4020.00M | -1862.00M |
| Free cash flow | 747.00M | 363.00M | 4572.00M | 4020.00M | -560.00M |
Sector: Financial Services Industry: Asset Management
|
Stock Name
|
Change
(GBX) |
Price
(GBX) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
|---|---|---|---|---|---|---|---|
| III 3I Group PLC |
7.00 0.30% |
2378.00 | 4.16 | 8.35 | 4.15 | 0.96 | 4.41 |
| MNTN Schiehallion Fund Ltd |
-0.01 0.46% |
2.18 | 0.05 | - | 4.35 | 1.25 | 5.65 |
| BHMU BH Macro Limited |
- -% |
4.29 | 0.09 | - | 39.01 | 0.71 | 6.47 |
| TFG Tetragon Financial Group Ltd |
0.15 1.00% |
15.10 | 0.02 | 7.04 | 1.16 | 0.31 | 2.06 |
| BPCR BioPharma Credit PLC |
0.00 0.41% |
0.98 | 0.09 | - | 6.73 | 0.91 | 7.95 |
3i Group plc is a private equity firm specializing in mature companies, growth capital, middle markets, infrastructure, and management leveraged buyouts and buy-ins. The firm also provides infrastructure financing and debt management. For debt management, it invests in senior and mezzanine corporate debt in typically large and private companies in United Kingdom, Europe, Asia, and North America. It makes private equity investments in business and technology services, financial services, consumer and private label, software and service, healthcare, consumption and distribution, media and telecom, renewable energy, wind, and industrial technology sector. Within business and technology services, the firm seeks to invest in sub sectors such as testing, inspection and certification; intelligent outsourcing, BPO and consultancy; human capital including staffing, governance, risk and compliance, services to pharmaceutical companies, vertical application software, education and training businesses; facilities management; support services to industrial sectors such as oil and gas and utilities; human resources outsourcing and advising; recruitment; logistics and infrastructure support services including distribution, waste, and rental. In the consumer sector, it focuses on, multi-unit roll out, omni-channel propositions, niche branded consumer goods, polarization, health and wellness, ageing population, millennials, consumer goods; e-commerce; retail; food and drinks; private label CMO and leisure. In the healthcare sector, the firm focuses on outsourced medical device manufacturing & services, outsourced pharmaceutical manufacturing & services, bioprocessing supply chain, life science tools and diagnostics, wellness & consumer health products, personalized medicine, pharmaceuticals and biotechnology including specialty pharma, generics or OTC, drug delivery, and animal health; healthcare services including activities such as elderly and specialty care, including caring for people in their own homes, in hospital and in co
| Name | Title | Year Born |
|---|---|---|
| Mr. Simon A. Borrows | CEO & Exec. Director | 1959 |
| Mr. James Graham Hatchley | Group Fin. Director & Director | 1967 |
| Ms. Jasi Halai | Group Financial Controller, COO & Director | 1978 |
| Ms. Silvia Santoro | Director of Investor Relations | NA |
| Mr. Kevin J. Dunn | Gen. Counsel & Company Sec. | 1963 |
| Ms. Kathryn van der Kroft | Director of Communications | NA |
| Mr. Julien Marie | Chief HR Officer | NA |
| Mr. Alastair Richardson | Director & Head of Legal - Private Equity | NA |
| Mr. Tony Lissaman | Chief Operating Officer of Private Equity | NA |
| Mr. Jonathan Crane | Partner & Head of Industrial | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.